In the guidelines, the CDC lays out the following three categories:
1. High risk. People are at high risk for Ebola if they have experienced the following:
• Percutaneous or mucous membrane exposure to blood or body fluids of a symptomatic Ebola patient
• Exposure to blood or body fluids of a symptomatic Ebola patient without proper personal protective equipment
• Processing the blood or body fluids of a symptomatic Ebola patient without proper PPE or biosafety precautions
• Direct contact with a dead body without PPE in a country with a widespread Ebola outbreak
• Living in the immediate household or provided care to a symptomatic Ebola patient
2. Some risk. This category includes people who had close contact with a symptomatic Ebola patient in households, a healthcare facility or community. Close contact is being within about three feet of a person while he or she was showing Ebola symptoms without proper PPE.
3. Low (but not zero) risk. This category includes people who were in a country with widespread Ebola infections but with no known exposure, having brief contact with a person in early stages of Ebola virus disease or while showing symptoms, or having traveled on an airplane with a symptomatic Ebola patient.
There is also a “no identifiable risk” category.
See the full guidance here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
